7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      2-methoxyestradiol does not inhibit superoxide dismutase.

      Archives of Biochemistry and Biophysics
      Aconitate Hydratase, metabolism, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, pharmacology, Epinephrine, Estradiol, analogs & derivatives, Fumarate Hydratase, HL-60 Cells, Humans, Indicators and Reagents, L-Lactate Dehydrogenase, Oxygen, Phenanthridines, Protein Binding, Superoxide Dismutase, antagonists & inhibitors, Tetrazolium Salts, Time Factors

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          It has been reported in the literature that the endogenous estrogen metabolite 2-methoxyestradiol (2-ME) inhibits both manganese and copper,zinc superoxide dismutases (Mn and Cu,Zn SODs) and that this mechanism is responsible for 2-ME's ability to kill cancer cells. In fact, as demonstrated using several SOD assays including pulse radiolysis, 2-ME does not inhibit SOD but rather interferes with the SOD assay originally used. Nevertheless, as confirmed by aconitase inactivation measurements and lactate dehydrogenase release in human leukemia HL-60 cells, 2-ME does increase superoxide production in these cells and is more toxic than its non-O-methylated precursor 2-hydroxyestradiol. Other mechanisms previously suggested in the literature may explain 2-ME's ability to increase intracellular superoxide levels in tumor cells. Copyright 2001 Academic Press.

          Related collections

          Author and article information

          Comments

          Comment on this article